TCM
IOVA icon

Tang Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Tang Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-543,760
Closed -$1.18M – 130
2025
Q3 		$1.18M Sell
543,760
-1,256,240
-70% -$2.97M 0.05% 150
2025
Q2 		$3.1M Hold
1,800,000
– – 0.16% 106
2025
Q1 		$5.99M Buy
1,800,000
+1,300,000
+260% +$6.7M 0.33% 70
2024
Q4 		$3.7M Hold
500,000
– – 0.24% 85
2024
Q3 		$4.7M Hold
500,000
– – 0.34% 77
2024
Q2 		$4.01M Hold
500,000
– – 0.41% 65
2024
Q1 		$7.41M Sell
500,000
-500,000
-50% -$5.82M 0.77% 46
2023
Q4 		$8.13M Buy
+1,000,000
New +$5.23M 0.75% 36

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return